European Research Ranking
Home
Methods
Rankings
Institutions
Countries
Updates
Search
Feedback
Projects
SANOFIAVENTIS
- France
Project overview (since 2010-01-01):
next >>
Start date
Project
acronym
role
funding
partners
2022-01-01
FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem
FACILITATE
participant
3.260.000
29
2021-11-01
European platform for neurodegenerative disorders
EPND
participant
9.680.000
29
2021-11-01
Preparing for RSV Immunisation and Surveillance in Europe
PROMISE
participant
3.744.375
22
2021-10-01
Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies
SCREEN4CARE
participant
11.938.569
37
2021-09-01
Innovations to accelerate vaccine development and manufacture
Inno4Vac
participant
18.600.000
41
2021-07-01
Real World Handling of Protein Drugs - Exploration, Evaluation and Education
RealHOPE
participant
3.139.984
27
2021-02-01
Central Repository for Digital Pathology
BIGPICTURE
participant
32.319.825
51
2020-11-01
Accelerating Research & Development for Advanced Therapies
ARDAT
participant
11.773.000
34
2020-10-01
H2O Health Outcomes Observatory
H2O
participant
10.476.687
25
2020-09-01
Prioritisation and Risk Evaluation of Medicines in the EnviRonment
PREMIER
participant
4.550.000
25
2020-05-01
Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA
INNODIA HARVEST
participant
5.999.055
41
2020-01-01
Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies
ImmUniverse
participant
15.500.000
28
2019-12-01
Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies
imSAVAR
participant
10.999.316
28
2019-11-01
Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases
IDEA-FAST
participant
20.997.523
47
2019-11-01
EU Patient- cEntric clinicAl tRial pLatform
EU-PEARL
participant
12.004.953
37
2019-09-01
Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions
3TR
participant
40.273.192
70
2019-09-01
Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials
Trials@Home
participant
19.036.998
33
2019-04-01
Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation
ConcePTION
participant
15.299.991
53
2019-04-01
Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement
MOBILISE-D
participant
25.395.897
35
2019-04-01
Biomarkers in Atopic Dermatitis and Psoriasis
BIOMAP
participant
10.500.000
32
2019-03-01
Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts
IMMUcan
participant
17.830.000
28
2019-03-01
CARdiomyopathy in type 2 DIAbetes mellitus
CARDIATEAM
participant
6.700.000
21
2019-03-01
Efficiently Networking European Neurodegeneration Research
NEURONET
participant
1.199.125
10
2019-03-01
Neurotoxicity De-Risking in Preclinical Drug Discovery
NeuroDeRisk
participant
5.331.000
18
2019-02-01
Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
TransBioLine
participant
13.999.998
29
2019-01-01
Vaccines and Infectious Diseases in the Ageing PopuLation
VITAL
participant
5.499.882
24
2019-01-01
Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain
IM2PACT
participant
9.000.000
27
2018-12-01
European Screening Centre; Unique Library for Attractive Biology
ESCulab
participant
18.249.993
20
2018-11-01
European Health Data and Evidence Network
EHDEN
participant
14.105.750
22
2018-07-01
Research empowerment on solute carriers (ReSOLUTE)
ReSOLUTE
participant
12.000.000
14
2018-06-01
The GetReal Initiative
GetReal Initiative
participant
1.750.000
17
2018-05-01
conect4children (COllaborative Network for European Clinical Trials For Children)
c4c
participant
67.000.000
47
2018-05-01
Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production
iConsensus
participant
4.700.000
19
2018-05-01
Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope
PIONEER
participant
6.000.000
34
2018-05-01
Hypoglycaemia - REdefining SOLutions for better liVEs
Hypo-RESOLVE
participant
13.450.057
23
2018-03-01
Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.
PARADIGM
participant
4.498.931
35
2017-11-01
Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections
COMBACTE-CDI
participant
2.312.305
14
2017-11-01
Liver Investigation: Testing Marker Utility in Steatohepatitis
LITMUS
participant
15.797.881
56
2017-10-01
European Quality In Preclinical Data
EQIPD
participant
4.495.523
30
2017-09-01
Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management
eTRANSAFE
participant
20.000.000
27
2017-09-01
Rheuma Tolerance for Cure
RTCure
participant
6.000.000
20
2017-07-01
Development of Robust and Innovative Vaccine Effectiveness
DRIVE
participant
8.999.813
15
2017-02-01
Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055
DO-IT
participant
3.549.833
36
2017-02-01
Cardio Ultraefficient nanoParticles for Inhalation of Drug prOducts
CUPIDO
participant
6.094.781
13
2017-01-01
Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106
IB4SD-TRISTAN
participant
12.000.000
21
2017-01-01
Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030
TransQST
participant
8.000.000
23
2017-01-01
REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019
RESCEU
participant
14.498.125
18
2017-01-01
Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalised medicine
MultipleMS
participant
14.721.453
22
2016-11-01
Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976
PHAGO
participant
8.838.000
20
2016-10-01
Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966
PREFER
participant
6.000.000
33
next >>